Managing Third-Party Relationships
|
|
- Justina Jacobs
- 5 years ago
- Views:
Transcription
1 Managing Third-Party Relationships PCC Canada June 2017 Presented by Stephan Ekmekjian and Darren Jones
2 Looking ahead to 2017 & beyond Accountability Integration of compliance and business Business ownership of traditional compliance responsibilities Criticality Defining key cost drivers for fee-for-service activities with HCOs and Payers Establishing repeatable FMV methodologies across a wide range of service types Access Understanding the necessity of market and patient access programs to ensure therapies are accessible to patients, as well as the increased risks associated with emerging commercial strategies Complexity Mapping third-party relationships and understanding relational risk Mining strategic insight from complex, messy data 2
3 Key questions to be addressed 1. Central risks associated with Third Party interactions 2. Focus Arrangements due diligence 3. How to effectively manage high-risk Third Parties where there are limited ex-ante risk mitigation options 4. HCP due diligence and tiering 3
4 Key points to be addressed Risks associated with third parties Focus Arrangements Due Diligence Managing highrisk third parties HCP Due Diligence and screening 4
5 Bribery and corruption happen in various ways through Third Parties Forms of bribery Facilitation payments Discounts Vacations Gifts Meals Employment/Internship Product samples Free or discounted equipment Risky Third parties Distributors Suppliers (other vendors along supply chain) Travel agencies Market access consultants Event & meeting management vendors HCP/Public officials engagements Customs agents Contract sales organizations Contract research organizations Medical society / association Patient advocacy organizations Third Parties interaction with HCPs, HCOs, or government officials is high risk due diligence is key 5
6 The development of systematic anti-corruption laws enhances the need for Third party (TP) monitoring North America USA Foreign Corrupt Practices Act (1977) USA Federal Anti Kick Back Statutes South America North America Europe UK Bribery Act (2010) German Act on Fighting Corruption in the Healthcare Sector (2016) France Sapin 2 (2016) Europe APAC APAC China Anti-bribery laws (1979, amended in 2011) South Korea The Act on the Prohibition of Improper Solicitation and Provision/Receipt of Money and Valuables (2016) UAE Penal Code (1987) Brazil Clean Company Act (2014) Colombian Transnational Corruption Act (2016) Mexican National Anti- Corruption system (2016) South America Africa Africa South African Prevention and Combating of Corrupt Activities Act (2004) Note: this is a non-exhaustive list of laws in place to fight corruption 6
7 What is a Focus Arrangement? Definition of Focus Arrangements The transactions and arrangements involving individuals or entities that may purchase or make referrals for company products Why Are They Important? Focus Arrangements require sensitivity when engaging government affiliated individuals and hospital systems such as Health Canada, to guard against anti-bribery and anti-corruption (FCPA) offences Suggested Steps to Follow Establish a centralized tracking system for all Focus Arrangements Track all remuneration between parties Keep service and activity logs Monitor leased space, supplies, equipment, etc. Establish and implement a written review and approval process for all Focus Arrangements Review all Focus Arrangements by a compliance officer annually Effective responses when suspected violations are discovered 7
8 Third party oversight and management: 5 key objectives Reliability As with all compliance programs, having consistent policies and procedures is essential to ensure program effectiveness. Consistency in areas such as initial screening/risk rating criteria, riskbased due diligence and approval/denial criteria are particularly important for TP oversight. Transparency The volume and diversity of TP engagements makes it challenging to gain visibility into key TP compliance data points such as: how many TPs are we actually engaged with? What do they do for us? Who vetted and approved the engagement? Business and approval rationale? Efficiency Efficiency in execution is vital given the geographic diversity and high volume of TP vendor engagements. For this reason, having tight and scalable policies and processes and/or some form of automation is important. Responsibility Shared or diffused responsibility among various stakeholders (compliance, finance, business, etc.) is common in TP management. This potential liability can be alleviated by a clear governance model with clear lines of review and approval, as well as structured policies and SOPs. Organization Maintaining accurate records and documentation of all TP arrangements and decision-making processes is an essential component of the TP program both for internal tracking and analytics as well as for regulatory compliance purposes. 8
9 Stages of Third Party Management & Oversight Life Cycle Identification Qualification Engagement & contracting Monitoring & auditing Renewal/exit strategy Business needs/rationale Initial screening Vendor questionnaire Vendor FMV or benchmarking analysis Risk-based due diligence Contracting Business stakeholder training Vendor training (as required) Risk-based & Purposeful Criteria to decide which vendors to monitor Exercise auditing rights Consideration: Who conducts the audit legal, compliance, internal audit department Pareto Principle 80% of corruption risk comes from 20% of vendors Risk-based due diligence renewal (periodic) o o Factors for termination Risk Internal resources Opportunities to correct Document conversations with business 9
10 Polaris Fair Market Value methodology is based on four key principles 1. Pay market rate for consultant s time not for the value of the service Since paying for time, rates should not vary based on type of service 2. Assure methodology supports higher fees for higher expertise Required to pay Thought Leader higher fees 3. Create an effective process for evaluating physician expertise and determining Thought Leader status (i.e. Local, Regional, National, etc.) Required to avoid kickback allegations 4. Ensure all elements of the fee determination are grounded on objective and transparent data analysis FMV methodology designed to be: Flexible, Consistent, Objective and Auditable 10
11 There are THREE equally important elements of FMV and each are necessary FMV Rates Tiering Model Activity Fees Fair Market Value Compensation While FMV rates based on objective data are a key control in the HCP engagement process they need to be supported by robust tiering models and consistent activity fee practice Compensation data used for FMV represents national averages o Industry does not routinely engage average physicians If you compensate based on tier, without a standard methodology it is difficult to ensure consistency If you lack consistency, the control is not working Depending on your rate methodology, the overpayment could be 20% - 80% depending on country and specialty FMV as a risk control is also strengthened if companies pay similar fees for similar activities based on standard service level expectations 11
12 Polaris FMV methodology differentiates levels of payment based on HCP expertise Expert premiums designed to recognize that markets will typically compensate higher levels of expertise with higher levels of pay Polaris methodology works with three tiers, defined on level of expertise, not on level of current earnings Tier 3: associated with average to above average expertise Tier 2: well recognized in their field within their country but with only limited recognition (if any) in other countries Tier 1: top experts in their field (e.g. top 5-10% in a country) # physicians Methodology for expert premiums (KOL) FMV base rate Opinion leaders Exception process FMV rate development needs to be combined with an effective methodology for determining HCP tiers based on standard criteria for recognizing medical and scientific expertise. 12
Global Third Party Due Diligence
Global Third Party Due Diligence PCC 2017 28 April 2017 Presented by Darren Jones, Cory LaBarge and Michael Clarke Key questions to be addressed 1. Central risks associated with Third Party interactions
More informationLatin America. Fair Market Value Update
Latin America Fair Market Value Update 1 st Latin American Pharmaceutical and Device Compliance Congress Sao Paulo, Brazil 3 October2012 International FMV Why create consistent payment methodology? World
More informationMini Summit XI: Third Party Management, including Pre-evaluation, Due Diligence, Contracting, Monitoring and Payment
Mini Summit XI: Third Party Management, including Pre-evaluation, Due Diligence, Contracting, Monitoring and Payment Shanghai 16:00 17:15 14 September, 2017 Disclaimer Please note that the views and opinions
More informationTransparency as a Good Business Practice
Transparency as a Good Business Practice Exploring How Transparency Can Drive Best Practices in Business Strategy August 2017 Polaris Management Partners Agenda Compliance Trends 2017-2018 Deriving Strategic
More informationOperational Considerations for Transparency. September 2011
Operational Considerations for Transparency September 2011 Current Global Regulatory Trends Type of Regulations/ Guidance Company s obligations Scope Sanctions/ Penalties State Laws Promotional spend reporting
More informationATTACHMENT B CORPORATE COMPLIANCE PROGRAM. In order to address any deficiencies in its internal controls, policies, and procedures
ATTACHMENT B CORPORATE COMPLIANCE PROGRAM In order to address any deficiencies in its internal controls, policies, and procedures regarding compliance with the Foreign Corrupt Practices Act ( FCPA ), 15
More informationAnti-Bribery and Anti-Corruption Guide for Third Party Sellers working for or on behalf of Cardinal Health
Anti-Bribery and Anti-Corruption Guide for Third Party Sellers working for or on behalf of Cardinal Health Our COMMITMENT& EXPECTATIONS This guide is designed to help you understand our anti-bribery and
More informationATTACHMENT C CORPORATE COMPLIANCE PROGRAM
ATTACHMENT C CORPORATE COMPLIANCE PROGRAM In order to address deficiencies in its internal controls, policies, and procedures regarding compliance with the Foreign Corrupt Practices Act ( FCPA ), 15 U.S.C.
More informationINTEGRITY COMPLIANCE GUIDELINES
AFRICAN DEVELOPMENT BANK GROUP African Development Bank Group Integrity and Anti-Corruption Department INTEGRITY COMPLIANCE GUIDELINES 1 1. Prohibition of Misconduct A clearly articulated and visible prohibition
More informationCOMBATING BRIBERY & CORRUPTION THROUGH INFORMATION INTELLIGENCE
COMBATING BRIBERY & CORRUPTION THROUGH INFORMATION INTELLIGENCE SETTING THE CONTEXT Anti-bribery and corruption continues to be a high priority Sustained enforcement and increasing regulator expectations,
More information2/12/2014. Physician Hospital Integration 1. Physician-Hospital Integration Compliance Considerations. Agenda
Physician-Hospital Integration Compliance Considerations Frank E. Sheeder III Chair, Health Care Enforcement and Compliance Practice DLA Piper LLP (US) 214-743-4560 frank.sheeder@dlapiper.com Agenda 1.
More informationMini Summit VI - MANAGING THIRD PARTY RELATIONSHIP RISKS
Mini Summit VI - MANAGING THIRD PARTY RELATIONSHIP RISKS Third-party risks FCPA prosecutions frequently cite use of local agents to pay bribes and conceal payments FCPA prohibits both direct or indirect
More informationCORPORATE COMPLIANCE PROGRAM
-- -- ~-1~ _ \ ~ CORPORATE COMPLIANCE PROGRAM In order to address any deficiencies in its internal controls, policies, and procedures regarding compliance with the Foreign Corrupt Practices Act ("FCPA"),
More informationNew Trends in the Use of Fair Market Value Concepts. PCF Disclosure, Transparency, and Aggregate Spend Conference February 6, 2014
New Trends in the Use of Fair Market Value Concepts PCF Disclosure, Transparency, and Aggregate Spend Conference February 6, 2014 Agenda Today s Speakers 4 Today s Discussion Topics 6 Question and Answer
More informationI. GENERAL STATEMENT. Corporate Procedure Number: IMCP Subject: Ethics and Anti-Corruption. Date Issued: March 11, 2016
I. GENERAL STATEMENT Iochpe-Maxion S.A. is committed to the highest ethical standards and to conducting its business in accordance with all applicable laws and regulations. The terms established in this
More informationAdvanced Contracting Course
Advanced Contracting Course Stephanie Levin, AD, Commercial Data Acquisition & Scouting Bayer Healthcare Leslie Yendro, VP Business Development Avella Specialty Pharmacy Agenda Introduction Common Types
More informationWestRock is committed to honest and ethical business practices. All forms of bribery are forbidden.
POLICY NAME: DEPT/GROUP: POLICY SCOPE: POLICY REGION: ANTI-BRIBERY LEGAL DEPARTMENT ALL EMPLOYEES GLOBAL REVISION DATE: 4/13/2018 OWNER JOSEPH HUTCHISON WestRock is committed to honest and ethical business
More informationQuestionnaire: Anti-Corruption Compliance Program Benchmarking Assessment
Appendix A Questionnaire: Anti-Corruption Compliance Program Benchmarking Assessment Anti-Corruption Compliance Program Benchmarking Assessment A. General information on the group B. Anti-corruption compliance
More informationANTI-CORRUPTION POLICY December 2017
ANTI-CORRUPTION POLICY www.ngahr.com Document Control Document Information Document Title Anti-Corruption Policy Document Owner Head of Compliance & Privacy Document Author XXX XXX Issue Date December
More informationAmgen GLOBAL CORPORATE COMPLIANCE POLICY
1. Scope Applicable to all Amgen Inc. and subsidiary or affiliated company staff members, consultants, contract workers, secondees, and temporary staff worldwide ( Covered Persons ). Consultants, contract
More informationEvaluating and Certifying Compliance Programs
Evaluating and Certifying Compliance Programs Claire TETART, Certification Manager, ETHIC Intelligence Maxime GOUALIN, Business Ethics & Human Rights Manager, Schneider Electric ETHIC Intelligence Certification
More informationCutting Edge Solutions For Managing GMET Risk
Cutting Edge Solutions For Managing GMET Risk 1 MICHAEL VOLKOV THE VOLKOV LAW GROUP LLC MVOLKOV@VOLKOVLAW.COM (240) 505-1992 Business Courtesies Generally 2 There are many different reasons Business Courtesies
More informationMini Summit 11 Best Practice in HCP / HCO Management to Reduce Compliance Risk and Enhance Efficiency
Mini Summit 11 Best Practice in HCP / HCO Management to Reduce Compliance Risk and Enhance Efficiency 18 th ASIA PACIFIC PHARMACEUTICAL AND MEDICAL DEVICE ETHICS AND COMPLIANCE CONGRESS September 10-12,
More informationThird Party Distributor Monitoring Program and Measuring Success
Third Party Distributor Monitoring Program and Measuring Success Sapan Singh Director Compliance, Stryker Corporation Emily C. Huebener Fraud Investigation & Dispute Services Ernst & Young, LLP Any views
More informationSunshine Act and Beyond: Improving Policies and Strategies
Helping companies identify and manage their compliance and commercial risk. C O M P L I A N C E IMPLEMENTATION SERVICES Sunshine Act and Beyond: Improving Policies and Strategies Presented by Vahan Minassian,
More informationBritish Standard BS Specification for an Anti-bribery Management System. Summary
British Standard BS 10500 Specification for an Anti-bribery Management System Summary BACKGROUND BSI Standards is the UK's National Standards Body. It is the UK representative at the International Organisation
More informationThird-party risk management. EY Integrity Diligence
Third-party risk management EY Integrity Diligence A challenging landscape Understanding who you conduct business with has become more than just good business practice; it is increasingly smart compliance.
More informationAnti-Bribery Policy. for you for your community not for profit. Date: Head of HR. Author:
Anti-Bribery Policy Date: Author: 11.07.17 Head of HR for you for your community not for profit Control box : Document owner: Reviewed by: Claire Knight Claire Knight Approved by and date: Head of HR July
More informationIdentifying and Mitigating Third Party Risk Conducting Risk-Based Anti-Corruption, Anti-bribery Due Diligence
Identifying and Mitigating Third Party Risk Conducting Risk-Based Anti-Corruption, Anti-bribery Due Diligence Jennafer B. Watson Chief Compliance Officer Layne Christensen Diana M. Lutz, Chief Ethics and
More informationPCF Analytics Workshop
PCF Analytics Workshop Asking the Right Risk Questions to Power Your Advanced Analytics Strategy November 7, 2018 Welcome! 19th Annual Pharmaceutical and Medical Device Compliance Congress Preconference
More informationBest Practices for Vendor Risk Profiling
Best Practices for Vendor Risk Profiling Presented By Michael Volkov CEO & Founder, Volkov Law Group Stephen Gooding Director, Product Specialists, NAVEX Global Copyright 2019 NAVEX Global, Inc. All Rights
More informationRules of Engagement for MSLs - Appropriate Interactions with Internal and External Stakeholders
Rules of Engagement for MSLs - Appropriate Interactions with Internal and External Stakeholders Daniel Snyder, PhD Medical Director, Neurology North America Medical Affairs Ipsen Biopharmaceuticals, Inc.
More informationCONFLICT OF INTEREST POLICY
CONFLICT OF INTEREST POLICY Compliance & Ethics Version 3.1 January 5, 2018 CONFLICT OF INTEREST POLICY Compliance & Ethics Policy Owner: Emily Grymes, Director, Global Compliance & Ethics Policy Approver:
More informationChina Compliance Roundtable RDPAC Legal and Compliance Working Group Best Practices Task Force
China Compliance Roundtable RDPAC Legal and Compliance Working Group Best Practices Task Force September 11, 2012 Agenda 1. Status Report the RDPAC Code 2. Emerging Trends China 2012 1. General 2. T&E
More informationANTI-BRIBERY AND ANTI-CORRUPTION POLICY
Amended to May 18, 2017 ANTI-BRIBERY AND ANTI-CORRUPTION POLICY Table of Contents Heading Page Number INTRODUCTION 1 PURPOSE 2 SCOPE 2 POLICIES 2 Bribery 2 Policy 2 Exceptions 3 Gifts 3 Meal and Entertainment
More informationglobal solutions risk advisory services
global solutions risk advisory services who are we? PKF is a global family of legally independent firms bound together by a shared commitment to quality, integrity and the creation of clarity in a complex
More informationAsia Pacific Life Sciences Compliance Survey 2018 Executive Summary
Asia Pacific Life Sciences Compliance Survey 2018 Executive Summary APAC compliance survey 2018 v1.indd 1 9/6/2018 5:33:59 PM Key findings 01. Compliance function benchmarking The majority of Life Sciences
More informationIndustry insight and global experience: the intelligent connection
Life sciences sector Industry insight and global experience: the intelligent connection Fraud Investigation & Dispute Services Reactive response and proactive risk management Life sciences companies are
More informationInternational Trade Compliance Risk Mitigation Workshop
International Trade Compliance Risk Mitigation Workshop SCCE CEI October, 2015 Gwendolyn L. Hassan, JD, CCEP CNH Industrial America LLC Managing Attorney Regulatory and Compliance Peter Bradford, KPMG
More informationInternational Trade Compliance Risk Mitigation Workshop
International Trade Compliance Risk Mitigation Workshop SCCE CEI October, 2015 Gwendolyn L. Hassan, JD, CCEP CNH Industrial America LLC Managing Attorney Regulatory and Compliance Peter Bradford, KPMG
More informationTrends in Aggregate Spend and Disclosure Reporting and Compliance 2011 *Preliminary Results
Trends in Aggregate Spend and Disclosure Reporting and Compliance 2011 *Preliminary Results Preliminary Results 2 nd Annual Industry-wide Survey March 2011 Agenda Overview Reporting Practices and Investment
More informationGlobal Anti-Corruption Programs:
Global Anti-Corruption Programs: Advanced Practice and Effectively Managing Risk Las Vegas, Nevada Jeff Killeen Compliance Attorney Investigations, 3M Elliott Leary Managing Director, Freeh Group International
More informationTopics for Discussion
Reviewing & Managing Third Party Compliance Marjorie W. Doyle, JD, CCEP-F, Managing Director, Aegis Compliance & Ethics Center, LLP with input from Diana Lutz SCCE Midwest Regional Conference, April 27,
More informationDocument Type Doc ID Status Version Pages Procedure INDGPEI Effective to 11. EI Policy General Principles governing External Interactions
Document Type Doc ID Status Version Pages Procedure INDGPEI Effective 6.0 1 to 11 Title of SOP: General Principles governing External Interactions EI Policy General Principles governing External Interactions
More informationGlobal Challenge: Conducting Background Checks. 7 February, 2014
Global Challenge: Conducting Background Checks 7 February, 2014 Agenda Introductions Background checks: relevance and framework Practical example: implementing background checks at Grünenthal Questions
More informationHealth care professionals payment transparency in Ontario Prepare for province s version of Sunshine Act
Health care professionals payment transparency in Ontario Prepare for province s version of Sunshine Act This page has been intentionally left blank The dawn of payment disclosure requirements The relationship
More informationHilton Responsible Sourcing Policy
Hilton Commitment to Travel with Purpose Travel with Purpose is Hilton's corporate responsibility commitment to providing shared value to its business and communities in four areas - creating opportunities
More informationMODERN SLAVERY STATEMENT
2016/17 MODERN SLAVERY STATEMENT CP FOODS (UK) Limited is part of a global business working with leading retailers, manufacturers, and restaurants to supply great foods Our Business and Supply Chains The
More informationESTERLINE ANTI-CORRUPTION PROGRAM CHARTER
ESTERLINE ANTI-CORRUPTION PROGRAM CHARTER Anti-Corruption Program Overview Introduction At Esterline, we win business based on the superiority of our products and services, and never as a result of bribery
More informationMESSAGE FROM LEADERSHIP
CODE OF CONDUCT MESSAGE FROM LEADERSHIP Brooks Health System is committed to the highest standards of ethics and integrity. Our environment is constantly changing, and that change results in challenges
More informationTHE FIDI ANTI-BRIBERY AND ANTI-CORRUPTION CHARTER. v. 1.2
THE FIDI ANTI-BRIBERY AND ANTI-CORRUPTION CHARTER v. 1.2 JULY 2015 Leading The Fight against Corruption FIDI is determined to lead the relocation industry by taking a clear stand against bribery and corruption.
More informationDaiichi Sankyo Group Global Anti-Bribery & Anti-Corruption Policy
Daiichi Sankyo Group Global Anti-Bribery & Anti-Corruption Policy 1/8 TABLE OF CONTENTS 1. PURPOSE... 3 2. SCOPE... 3 3. DEFINITIONS... 3 4. COMPLIANCE WITH APPLICABLE LAWS, REGULATIONS AND INDUSTRY CODES...
More informationLI & FUNG LIMITED ANNUAL REPORT 2016
52 Our approach to risk management We maintain a sound and effective system of risk management and internal controls to support us in achieving high standards of corporate governance. Our approach to risk
More informationTo participate in polling
in the Modern Multi-National: Aligning Trade with Your & Ethics Program Suzanne Bullitt Director, Global Trade Strategy & Eastman Chemical Company This Session Uses Polling To participate in polling Download
More informationImplementing and Managing an Effective Anti Corruption Compliance Program
Implementing and Managing an Effective Anti Corruption Compliance Program Mvolkov@volkovlaw.com http://corruptioncrimecompliance.com effective compliance The Importance of an Ethics and Compliance Program
More informationBusiness Relationship Statement
Business Relationship Statement WELCOME Dear HealthTrust Suppliers and Potential Suppliers, Thank you for all you do to support our members and other healthcare providers. Without your cooperation, HealthTrust
More informationDetecting and responding to fraud: making the intelligent connection Fraud Investigation & Dispute Services
Investigations Detecting and responding to fraud: making the intelligent connection Fraud Investigation & Dispute Services We make the connection between knowledge and insight Our dedicated global team
More informationCross-Border Expert Engagements A Global Case Study May 2013
Cross-Border Expert Engagements A Global Case Study May 2013 1 Agenda Introductions Industry Landscape The Challenge Solution Overview Business Outcome 2 Introductions Bio s Iain Holloway-McLean, Global
More informationAUTO-EVALUATION OF LAFARGE AGAINST TRANSPARENCY INTERNATIONAL S BUSINESS PRINCIPLES
AUTO-EVALUATION OF LAFARGE AGAINST TRANSPARENCY INTERNATIONAL S BUSINESS PRINCIPLES Overview Development process and leadership: Since the program has not been fully developed yet, this stage is difficult
More informationWhat should your compliance function look like?
From Start-Up to IPO How to Design and Build a Compliance Program From Scratch Dominic F. Perella Sean Coutain October 2017 What should your compliance function look like? Start With the Legal Frameworks
More informationEltel UN Global Compact report on period August 2015 July CEO statement on Eltel progress to comply with the UNGC ten principles
Eltel UN Global Compact report on period August 2015 July 2016 CEO statement on Eltel progress to comply with the UNGC ten principles 2015 was a milestone year in Eltel s history. First we were stock listed
More informationSafety Integrity Excellence People and Citizenship
OPG Supplier Code of Conduct Safety Integrity Excellence People and Citizenship Ontario Power Generation is an Ontario-based electricity generation company whose principal business is the generation and
More informationBUSINESS PRINCIPLES FOR PROMOTING INTEGRITY IN THE PHARMACEUTICAL SECTOR
BUSINESS PRINCIPLES FOR PROMOTING INTEGRITY IN THE PHARMACEUTICAL SECTOR A REGIONAL MULTI-STAKEHOLDER INITIATIVE FOR LATIN AMERICA LED BY TRANSPARENCY INTERNATIONAL UK S PHARMACEUTICALS & HEALTHCARE PROGRAMME
More informationAcceleron Pharma Inc. Code of Business Conduct and Ethics
I. INTRODUCTION Acceleron Pharma Inc. Code of Business Conduct and Ethics (Amended & Restated as of March 1, 2018) This Code of Business Conduct and Ethics ( Code ) provides a general statement of the
More informationBribery and Corruption
Bribery and Corruption Anti-Corruption Programs 2018 Association of Certified Fraud Examiners, Inc. Discussion Questions 1. What companywide policies does your organization have in place to address the
More informationEFPIA codex on transparency of value exchange more sunshine or rain?
Automotive the way we see it EFPIA codex on transparency of value exchange more sunshine or rain? How the EFPIA codex wil create new challenges for the industry Pharma needs to create transparency for
More informationAnderson Compliance Program
POLICY: Gifts, Gratuities and Business Courtesies 02/15 Anderson Compliance Program GIFTS, GRATUITIES, AND BUSINESS COURTESIES POLICY Purpose: The federal anti-kickback statute prohibits the acceptance
More informationWORKING WITH THIRD PARTIES POLICY POLICY ADOPTED MARCH 2015, REVISED FEBRUARY 2017
WORKING WITH THIRD PARTIES POLICY POLICY ADOPTED MARCH 2015, REVISED FEBRUARY 2017 TABLE OF CONTENTS WORKING WITH THIRD PARTIES POLICY... 3 Introduction... 3 Working with third parties... 3 Due diligence
More informationFCPA COMPLIANCE PROGRAMS
FCPA COMPLIANCE PROGRAMS JIMMY S. PAPPAS INTERNATIONAL INTERNAL INVESTIGATIONS CONFERENCE FRANKFURT, GERMANY DECEMBER 7, 2012 FCPA COMPLIANCE PROGRAMS - OVERVIEW! An effective compliance program is: A
More informationBearing the Bad News Reporting to the Board on Internal Corruption. Peter Dent, National Leader Deloitte Forensics September 11, 2013
Bearing the Bad News Reporting to the Board on Internal Corruption Peter Dent, National Leader Deloitte Forensics September 11, 2013 Agenda Assessment of Risk in Canada Recent trends in enforcement activity
More informationAn Overview of ISO Anti-Bribery Management System Standard
An Overview of ISO 37001 Anti-Bribery Management System Standard Neill Stansbury Chair: ISO 37001 Project Committee Co-founder and Director: GIACC www.giaccentre.org 2017 GIACC 1 Bribery is a significant
More informationOutdated and/or Ineffective Laws and Regulations. Jane Thorpe, J.D. Milken Institute School of Public Health George Washington University
Outdated and/or Ineffective Laws and Regulations Jane Thorpe, J.D. Milken Institute School of Public Health George Washington University Outdated and ineffective laws and regulations Shifting from Volume
More informationThis Session Uses Polling
A Tale of Two Companies This Session Uses Polling To Participate in polling Download SCCE Mobile in your app mobile store. Then under the agenda find this session, scroll to the bottom and click Poll Question
More informationImplementing effective third-party frameworks in the life sciences industry leading practices and challenges
Implementing effective third-party frameworks in the life sciences industry leading practices and challenges Introduction The recent enforcement environment has reinforced the risks associated with third-party
More informationBusiness integrity and sustainable growth: making the intelligent connection Fraud Investigation & Dispute Services
Business Integrity and Corporate Compliance Business integrity and sustainable growth: making the intelligent connection Fraud Investigation & Dispute Services We make the connection between integrity,
More informationFraud in focus March Fraud & Corruption in the Victorian Public Sector learnings and insight for 2017 and beyond
Fraud in focus March 2017 Fraud & Corruption in the Victorian Public Sector learnings and insight for 2017 and beyond Introduction The Victorian Public Sector has a comprehensive integrity framework with
More informationLeading Practices to Leverage Forensic Data Analytics in Compliance Monitoring and Investigation
Leading Practices to Leverage Forensic Data Analytics in Compliance Monitoring and Investigation Table of contents 1 Proactive Compliance Monitoring 2 EY s First Annual Global Forensic Data Analytics Survey
More informationDFS NY A strategic approach to dealing with the final rule. August 2017
DFS NY 504.3 A strategic approach to dealing with the final rule August 2017 Analytical contacts Alan Lloyd Paris Director, Financial Crime and Compliance Analytics Email: alan.paris@crisil.com Anurag
More informationCOMMUNICATION ON PROGRESS REPORT 2017
COMMUNICATION ON PROGRESS REPORT 2017 1 Aspen Pharmacare Holdings Limited Communication on Progress report Communication on Progress report in respect of Aspen s application of the United Nations Global
More information2017 The Global ABB Integrity Program.
2017 The Global ABB Integrity Program www.abb.com/integrity Tone from the Top Don t Look the Other Way A culture of integrity is a prerequisite for a world-class business. Many valuable customers choose
More informationAPPROVED. Anti-Bribery and Corruption Policy OBJECTIVES PRINCIPLES WOODSIDE POLICY. Prohibition on corruption. Gifts and entertainment principles
WOODSIDE POLICY Anti-Bribery and Corruption Policy OBJECTIVES Woodside is committed to conducting its business and activities with integrity. To achieve this objective: Woodside will not engage in corrupt
More informationHealthcare Professionals Privacy Notice. Date: 1 February 2019
Healthcare Professionals Privacy Notice Date: 1 February 2019 Biogen Idec Limited ( Biogen ) interacts with healthcare professionals ( HCPs ) in many ways. This Privacy Notice describes how we collect
More informationANTI-CORRUPTION POLICY
ANTI-CORRUPTION POLICY CONTENTS 1. PREFACE... 3 1.1. ASTM s Commitment to Fighting Corruption... 3 1.2. Legislative Framework... 3 1.3. Recipients and Scope of Application... 3 2. INTRODUCTION... 4 2.1.
More informationHealthcare Professionals Privacy Notice. Date: 1 February 2019
Healthcare Professionals Privacy Notice Date: 1 February 2019 Biogen Sweden AB ( Biogen ) interacts with healthcare professionals ( HCPs ) in many ways. This Privacy Notice describes how we collect and
More informationSABIC SUPPLIER DUE DILIGENCE PROGRAMME
SABIC SUPPLIER DUE DILIGENCE PROGRAMME THE NEED FOR DUE DILIGENCE Being able to confidently demonstrate sustainable business practices is vital to commercial success, and is an essential requirement of
More informationAuditing: A Panel Discussion of Evolving Compliance Strategies
Auditing: A Panel Discussion of Evolving Compliance Strategies Ann E Lewis, VP and Senior Counsel, US Healthcare Law Compliance (Bristol-Myers Squibb) Monica Jonhart, Director, Auditing, US Healthcare
More informationRole Type Pay Band Location Duration Reports to: PB4/H Lagos Indefinite Procurement Manager W/A
Role Title Procurement Officer W/Africa Cluster (PCO) Role Information Role Type Pay Band Location Duration Reports to: Advisory, Policy and Expertise PB4/H Lagos Indefinite Procurement Manager W/A Role
More informationANTI-CORRUPTION AND BRIBERY POLICY
ANTI-CORRUPTION AND BRIBERY POLICY Policy statement It is our policy to conduct all of our business in an honest and ethical manner. We take a zero-tolerance approach to bribery and corruption and are
More informationStrategic Meetings Management: The Next Generation
Strategic Meetings Management: The Next Generation June 2017 AHM 2017 All Rights Reserved www.ahmdirect.com TABLE OF CONTENTS Content Introduction SMM: Then and Now SMM: The Wider Remit and Value Throughout
More informationARCADIS GENERAL BUSINESS PRINCIPLES. July 2016
ARCADIS GENERAL BUSINESS PRINCIPLES July 2016 ARCADIS GENERAL BUSINESS PRINCIPLES 1. INTRODUCTION At Arcadis we define our mission as: Our mission is to create exceptional and sustainable outcomes for
More informationSupply Chain Management
Supply Chain Management Isabelle Stauffer Madrid, January 2017 Agenda 01 02 03 04 RobecoSAM & Corporate Sustainability Assessment (CSA) Supply Chain Management An Overview RobecoSAM s Expectations on Companies
More informationProcurement Under the New Requirements 1
Requirements 1 Procurement under the New Requirements 1 Why This Session Is Needed New provisions in Uniform Guidance Changes to conflict of interest requirements in Uniform Guidance Distinctions between
More informationAcknowledgement of Aramco Overseas Company BV. Supplier Code of Conduct
IMPORTANT DOCUMENT PLEASE RETURN SIGNED ACKNOWLEDGEMENT Acknowledgement of Aramco Overseas Company BV Supplier Code of Conduct (Applicable to Vendors, Manufacturers, Contractors and Sub-Contractors) Aramco
More informationMitigating Corruption Risk When Acquiring Companies in High-Risk Jurisdictions
Mitigating Corruption Risk When Acquiring Companies in High-Risk Jurisdictions By Bill Olsen, Scott Nemeroff, Dan Reynolds and Alex Koltsov Grant Thornton The hallmark of merger and acquisition activity
More informationThe compliance implications of valuebased. October 2017
The compliance implications of valuebased healthcare October 2017 The compliance implications of value-based healthcare: questions you should be asking. While advances in research and technology have led
More informationPublic Procurement Reforms to enhance value for money
Public Procurement Reforms to enhance value for money 1. It is my pleasure to be here in the inaugural function of the Seminar on Public Procurement Reforms to enhance value for money being organized by
More informationManaging Compliance Risk in M&A, and Special Considerations for Joint Ventures
Managing Compliance Risk in M&A, and Special Considerations for Joint Ventures SCCE Upper Midwest Regional Conference April 26, 2013 Agenda Compliance risk and threat landscape overview Four areas we ll
More informationBribery and Research Integrity in Foreign Clinical Trials: Practical Strategies for Reducing Your Company s Compliance Risks
November 3, 2011 Bribery and Research Integrity in Foreign Clinical Trials: Practical Strategies for Reducing Your Company s Compliance Risks Sue Sefarian Health Care Compliance Officer Johnson & Johnson
More informationA Shared-Cost Approach to Anti-Bribery Compliance
12 th Annual Compliance & Ethics Institute A Shared-Cost Approach to Anti-Bribery Compliance Alexandra Wrage President, TRACE International Alexandra Wrage President TRACE International, Inc. Contact Information
More informationENHANCING CORPORATE GOVERNANCE
ENHANCING CORPORATE GOVERNANCE FOR BANKING ORGANISATIONS (September 1999) I. Introduction 1. There has been a great deal of attention given recently to the issue of corporate governance in various national
More information